By a News Reporter-Staff News Editor at Health& Medicine Week AbbVie, a global biopharmaceutical company, announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-lic
-Allegheny General Hospital, part of Allegheny Health Network, today announced that it will enroll patients in a clinical study to evaluate the safety and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection. With the emergence of difficult-to-manage strains of C. diff, CDI has become m
THE Punjab Medical Council has sent notices to 10 doctors after income tax authorities pointed out that multinational pharma companies had paid them crores of rupees in bribe for recommending their drugs. The pharma firms that had rained gifts on the doctors include Ranbaxy, E- Meditek, Intas, MSD, Merck, Lupin, Genins, Bayer, Glenmark, Bristol, No
By a News Reporter-Staff News Editor at Health& Medicine Week Arvinas LLC, a biotechnology company creating a new class of oncology drugs based on protein degradation, announced the appointment of Robert Kleinfield, Ph.D., as chief development officer of the company. Dr. Kleinfield brings over 20 years of product development and project leadershi
Release date- 09102015- Hershey, PA& Rockville, MD and Tokyo, Japan,- Immunomic Therapeutics, Inc., a company developing next generation vaccines based on the LAMP-vax platform, and Astellas Pharma Inc. today announced they have entered into an exclusive worldwide license agreement to the LAMP-vax products for the treatment or prevention of any and
*First study of the Ad26.ZEBOV/MVA-BN Filo prime-boost vaccination regimen in an Ebola outbreak country* Study being initiated on parallel track with multiple ongoing Phase 1 and 2 studies across U.S., Europe and Africa to support licensure of the vaccine regimen COPENHAGEN, Denmark, October 9, 2015- Bavarian Nordic A/S announced today the initi
About biopharmaceutical cold chain packaging. Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation.
On Oct 5, the Nobel Prize committee announced the 2015 winners of the Nobel Prize in Physiology or Medicine: William Campbell and Satoshi Omura for their work on a therapy against roundworm, shared with Tu Youyou, the first ever Nobel laureate working in traditional Chinese Medicine, for a therapy against malaria. Tu, the first native Chinese woman
WASHINGTON, Oct. 9- With prescription drug prices skyrocketing, Sen. Robert Califf as the new commissioner of the Food and Drug Administration because of his ties to the industry. "At a time when millions of Americans cannot afford to purchase the prescription drugs they need, we need a new leader at the FDA who is prepared to stand up to the phar
By a News Reporter-Staff News Editor at Health& Medicine Week Depomed, Inc. announced favorable decisions by the Patent Trial and Appeal Board of the United States Patent and Trademark Office that confirmed the patentability of all 23 claims of two Depomed patents subject to inter partes review proceedings initiated by Endo Pharmaceuticals.
According to news originating from Cheshire, United Kingdom, by NewsRx correspondents, research stated, "As the number of antibacterial medicines in the pipeline remains low, we anonymously surveyed pharmaceutical industry professionals on challenges and solutions for clinical development of these agents." Our news journalists obtained a quote from
Galectin Therapeutics' Executive Chairman to Discuss Silent Epidemic and Company's Role in Developing Treatments for NASH and Other Diseases at Robins Equity Research Roundup Conference. -Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that James Czirr, th
We are pleased that the FDA continues to acknowledge the current high unmet needs for patients with metastatic Merkel cell carcinoma through these recent regulatory designations for avelumab, said Dr. Luciano Rossetti, Head of Global Research& Development at Merck s biopharmaceutical business, Merck Serono. We look forward to working closely with t
Staving off generic competition for the acne drug over the next 5 years, Ranbaxy Pharmaceuticals, which Sun Pharmaceutical Industries acquired from the Japanese Daiichi Sankyo for $4 billion, has settled a patent suit with U.S.-listed drugmaker Actavis over a version of skin care drug Absorica. Sun Pharma said the settlement has seen Ranbaxy, toget
Release date- 09102015- NEW BRUNSWICK, N.J.,- Johnson& Johnson today announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pharmaceutical Companies. This is the first study conducted of Janssen's Ebola prime-boost vaccine regimen in a West African countr
Johnson& Johnson today announced the start of a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pharmaceutical Companies. This is the first study conducted of Janssen's Ebola prime-boost vaccine regimen in a West African country affected by the recent Ebola epidemic.
Phase IIB study with KUR-111 meets primary efficacy endpoint. Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products, today announces that positive results of a Phase IIb trial assessing the potential of KUR-111 in the treatment of patients with tibial plateau fractures that require
This report studies the global nuclear medicine equipment market for the forecast period of 2015 to 2020. This market is expected to reach USD 2.13 Billion by 2020 from USD 1.78 Billion in 2015, and is poised to grow at a CAGR of 3.6% during the forecast period. The global nuclear medicine equipment market is segmented on the basis of product, appl
Release date- 08102015- Merck KGaA, Darmstadt, Germany, and Pfizer today announced that the US Food and Drug Administration has granted avelumab*, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Fast Track designation for the treatment of metastatic Merkel cell carcinoma, a rare and aggressive type of skin cancer.1, 2.
The nation's second-largest nursing home pharmacy, PharMerica Corp., has agreed to pay $9.25 million to resolve allegations that it solicited and received kickbacks from pharmaceutical manufacturer Abbott Laboratories in exchange for promoting the prescription drug Depakote for nursing home patients. PharMerica is headquartered in Louisville,...
By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies have been presented. According to news reporting originating in Waltham, Massachusetts, by NewsRx journalists, research stated, "Amorphous solid dispersion can accelerate a project by improving dissolution rate and solubility, offering dose escalation flexibili
New Pharmaceutical Science Findings from Graz University of Technology Described. According to news reporting originating in Graz, Austria, by NewsRx journalists, research stated, "Over the last years, continuous manufacturing has created significant interest in the pharmaceutical industry. The news reporters obtained a quote from the research from
By a News Reporter-Staff News Editor at Health& Medicine Week When prescribing newly approved drugs, physicians rely on data from clinical trials to understand the benefits and risks of those drugs for patients. "We found that patients participating in clinical trials are younger and healthier than many of the patients who are receiving these dr
By a News Reporter-Staff News Editor at Drug Week A patent by the inventors Norman, Gary T.; Nuguru, Kalyan S.; Amin, Arun F.; Chandar, Sarath, filed on September 27, 2013, was published online on September 22, 2015, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9138413 is assigned to S
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Dwivedi, Shriprakash Dhar; Patel, Dhimant Jasubhai; Shah, Alpesh Pravinchandra; Khera, Brij, filed on September 8, 2014, was published online on September 22, 2015. The patent's assignee for patent number 9139527 i